BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Scoles DR. The merlin interacting proteins reveal multiple targets for NF2 therapy. Biochim Biophys Acta 2008;1785:32-54. [PMID: 17980164 DOI: 10.1016/j.bbcan.2007.10.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 30] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Osunkoya AO, Yin-Goen Q, Phan JH, Moffitt RA, Stokes TH, Wang MD, Young AN. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis. Hum Pathol 2009;40:1671-8. [PMID: 19695674 DOI: 10.1016/j.humpath.2009.05.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
2 Moura G, Lucena SV, Lima MA, Nascimento FD, Gesteira TF, Nader HB, Paredes-Gamero EJ, Tersariol I. Post-translational allosteric activation of the P2X7 receptor through glycosaminoglycan chains of CD44 proteoglycans. Cell Death Discov 2015;1:15005. [PMID: 27551441 DOI: 10.1038/cddiscovery.2015.5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
3 Bush ML, Oblinger J, Brendel V, Santarelli G, Huang J, Akhmametyeva EM, Burns SS, Wheeler J, Davis J, Yates CW, Chaudhury AR, Kulp S, Chen CS, Chang LS, Welling DB, Jacob A. AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas. Neuro Oncol 2011;13:983-99. [PMID: 21778190 DOI: 10.1093/neuonc/nor072] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 3.8] [Reference Citation Analysis]
4 Petrilli AM, Fernández-Valle C. Role of Merlin/NF2 inactivation in tumor biology. Oncogene 2016;35:537-48. [PMID: 25893302 DOI: 10.1038/onc.2015.125] [Cited by in Crossref: 164] [Cited by in F6Publishing: 145] [Article Influence: 23.4] [Reference Citation Analysis]
5 Morrow KA, Shevde LA. Merlin: the wizard requires protein stability to function as a tumor suppressor. Biochim Biophys Acta. 2012;1826:400-406. [PMID: 22750751 DOI: 10.1016/j.bbcan.2012.06.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
6 Ferrer M, Schulze A, Gonzalez S, Ferreiro V, Ciavarelli P, Otero J, Giliberto F, Basso A, Szijan I. Neurofibromatosis type 2: molecular and clinical analyses in Argentine sporadic and familial cases. Neurosci Lett 2010;480:49-54. [PMID: 20553997 DOI: 10.1016/j.neulet.2010.05.094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
7 Tanaka K, Eskin A, Chareyre F, Jessen WJ, Manent J, Niwa-Kawakita M, Chen R, White CH, Vitte J, Jaffer ZM, Nelson SF, Rubenstein AE, Giovannini M. Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2. Clin Cancer Res 2013;19:3856-70. [PMID: 23714726 DOI: 10.1158/1078-0432.CCR-12-3167] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
8 Yoon NK, Maresh EL, Elshimali Y, Li A, Horvath S, Seligson DB, Chia D, Goodglick L. Elevated MED28 expression predicts poor outcome in women with breast cancer. BMC Cancer 2010;10:335. [PMID: 20584319 DOI: 10.1186/1471-2407-10-335] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
9 De Muyt A, Zhang L, Piolot T, Kleckner N, Espagne E, Zickler D. E3 ligase Hei10: a multifaceted structure-based signaling molecule with roles within and beyond meiosis. Genes Dev 2014;28:1111-23. [PMID: 24831702 DOI: 10.1101/gad.240408.114] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 5.5] [Reference Citation Analysis]
10 Iglesias-Bartolome R, Torres D, Marone R, Feng X, Martin D, Simaan M, Chen M, Weinstein LS, Taylor SS, Molinolo AA, Gutkind JS. Inactivation of a Gα(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis. Nat Cell Biol 2015;17:793-803. [PMID: 25961504 DOI: 10.1038/ncb3164] [Cited by in Crossref: 96] [Cited by in F6Publishing: 90] [Article Influence: 13.7] [Reference Citation Analysis]
11 Omelyanchuk LV, Pertseva JA, Burns SS, Chang LS. Evolution and origin of HRS, a protein interacting with Merlin, the Neurofibromatosis 2 gene product. Gene Regul Syst Bio 2009;3:143-57. [PMID: 20054405 DOI: 10.4137/grsb.s3106] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Hummel M, Metzeler KH, Buske C, Bohlander SK, Mansmann U. Association between a prognostic gene signature and functional gene sets. Bioinform Biol Insights 2008;2:329-41. [PMID: 19812786 DOI: 10.4137/bbi.s1018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
13 Seo PS, Quinn BJ, Khan AA, Zeng L, Takoudis CG, Hanada T, Bolis A, Bolino A, Chishti AH. Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin. Exp Biol Med (Maywood) 2009;234:255-62. [PMID: 19144871 DOI: 10.3181/0809-RM-275] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
14 Perisic L, Rodriguez PQ, Hultenby K, Sun Y, Lal M, Betsholtz C, Uhlén M, Wernerson A, Hedin U, Pikkarainen T, Tryggvason K, Patrakka J. Schip1 is a novel podocyte foot process protein that mediates actin cytoskeleton rearrangements and forms a complex with Nherf2 and ezrin. PLoS One 2015;10:e0122067. [PMID: 25807495 DOI: 10.1371/journal.pone.0122067] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
15 Mosaddeghzadeh N, Kazemein Jasemi NS, Majolée J, Zhang SC, Hordijk PL, Dvorsky R, Ahmadian MR. Electrostatic Forces Mediate the Specificity of RHO GTPase-GDI Interactions. Int J Mol Sci 2021;22:12493. [PMID: 34830380 DOI: 10.3390/ijms222212493] [Reference Citation Analysis]
16 Lallemand D, Saint-Amaux AL, Giovannini M. Tumor-suppression functions of merlin are independent of its role as an organizer of the actin cytoskeleton in Schwann cells. J Cell Sci 2009;122:4141-9. [PMID: 19910496 DOI: 10.1242/jcs.045914] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
17 Daniels SM, Gatignol A. The multiple functions of TRBP, at the hub of cell responses to viruses, stress, and cancer. Microbiol Mol Biol Rev 2012;76:652-66. [PMID: 22933564 DOI: 10.1128/MMBR.00012-12] [Cited by in Crossref: 60] [Cited by in F6Publishing: 42] [Article Influence: 6.7] [Reference Citation Analysis]
18 Ahmad I, Yue WY, Fernando A, Clark JJ, Woodson EA, Hansen MR. p75NTR is highly expressed in vestibular schwannomas and promotes cell survival by activating nuclear transcription factor κB. Glia 2014;62:1699-712. [PMID: 24976126 DOI: 10.1002/glia.22709] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
19 Hennigan RF, Fletcher JS, Guard S, Ratner N. Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins. Sci Signal 2019;12:eaau8749. [PMID: 31015291 DOI: 10.1126/scisignal.aau8749] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
20 Plotkin SR, Halpin C, Blakeley JO, Slattery WH 3rd, Welling DB, Chang SM, Loeffler JS, Harris GJ, Sorensen AG, McKenna MJ, Barker FG 2nd. Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma. J Neurooncol 2009;93:61-77. [PMID: 19430883 DOI: 10.1007/s11060-009-9867-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
21 Pećina-Šlaus N. Merlin, the NF2 gene product. Pathol Oncol Res. 2013;19:365-373. [PMID: 23666797 DOI: 10.1007/s12253-013-9644-y] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
22 Gerber PA, Antal AS, Neumann NJ, Homey B, Matuschek C, Peiper M, Budach W, Bölke E. Neurofibromatosis. Eur J Med Res 2009;14:102-5. [PMID: 19380279 DOI: 10.1186/2047-783x-14-3-102] [Cited by in Crossref: 43] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
23 Schroeder RD, Angelo LS, Kurzrock R. NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations. Oncotarget 2014;5:67-77. [PMID: 24393766 DOI: 10.18632/oncotarget.1557] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]
24 Yu MA, Cho JG, Kim KI, Jo YJ, Sung JH, Yang HB, Park SG. Generation of med28 specific monoclonal antibodies. Monoclon Antib Immunodiagn Immunother 2015;34:30-5. [PMID: 25723281 DOI: 10.1089/mab.2014.0068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
25 Yi C, Kissil JL. Merlin in organ size control and tumorigenesis: Hippo versus EGFR? Genes Dev 2010;24:1673-9. [PMID: 20713513 DOI: 10.1101/gad.1964810] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
26 Li X, Chen H, Xue L, Pang X, Zhang X, Zhu Z, Zhu W, Wang Z, Wu H. p53 performs an essential role in mediating the oncogenic stimulus triggered by loss of expression of neurofibromatosis type 2 during in vitro tumor progression. Oncol Lett 2017;14:2223-31. [PMID: 28789444 DOI: 10.3892/ol.2017.6445] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
27 Schulz A, Zoch A, Morrison H. A neuronal function of the tumor suppressor protein merlin. Acta Neuropathol Commun 2014;2:82. [PMID: 25012216 DOI: 10.1186/s40478-014-0082-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
28 Kilili GK, Kyriakis JM. Mammalian Ste20-like kinase (Mst2) indirectly supports Raf-1/ERK pathway activity via maintenance of protein phosphatase-2A catalytic subunit levels and consequent suppression of inhibitory Raf-1 phosphorylation. J Biol Chem 2010;285:15076-87. [PMID: 20212043 DOI: 10.1074/jbc.M109.078915] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
29 Chinthalapudi K, Mandati V, Zheng J, Sharff AJ, Bricogne G, Griffin PR, Kissil J, Izard T. Lipid binding promotes the open conformation and tumor-suppressive activity of neurofibromin 2. Nat Commun 2018;9:1338. [PMID: 29626191 DOI: 10.1038/s41467-018-03648-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
30 Guo L, Moon C, Niehaus K, Zheng Y, Ratner N. Rac1 controls Schwann cell myelination through cAMP and NF2/merlin. J Neurosci 2012;32:17251-61. [PMID: 23197717 DOI: 10.1523/JNEUROSCI.2461-12.2012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 3.7] [Reference Citation Analysis]
31 Nix P, Hammarlund M, Hauth L, Lachnit M, Jorgensen EM, Bastiani M. Axon regeneration genes identified by RNAi screening in C. elegans. J Neurosci 2014;34:629-45. [PMID: 24403161 DOI: 10.1523/JNEUROSCI.3859-13.2014] [Cited by in Crossref: 65] [Cited by in F6Publishing: 51] [Article Influence: 8.1] [Reference Citation Analysis]